pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jul 9·1 min read
save

Mid-year roundup highlights top health-tech trends in 2026

Jul 9, 2026·read at Endpoints ↗Neutral

The editorial team notes that the first half of 2026 has been unusually active for health technology. Five major developments have been identified as the most significant so far.

One clear theme is the surge of artificial-intelligence firms moving into the healthcare space, aiming to apply their data-driven tools to clinical and operational challenges.

The roundup does not detail specific products or approvals, but emphasizes the broader shift toward digital solutions across the industry.

Readers are invited to sign up for full access to the article and related newsletters.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “The biggest health tech stories of 2026 — so far”

read at Endpoints ↗
83 words · retrieved Jul 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 5h agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 9h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 9h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 9h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 10h agoHealth tech investors are looking at bigger betsEndpoints